Diagnostic and Prognostic Markers in Preeclampsia: Maternal Health Indicators A Case-Control Study

Document Type : Case Study

Authors

1 Master Degree, Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University

2 Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University

3 Department of Medical Biochemistry, Faculty of Medicine, Alexandria University

Abstract

Preeclampsia is a pregnancy-related syndrome that is one of the frequent reasons for neonatal and maternal deaths and illness throughout the world. Preeclampsia affects roughly 2% to 8% of all pregnancies, resulting in more than 63,000 maternal fatalities per year around the world. Early detection of preeclampsia would allow for intervention and attentive monitoring, reducing the disorder's negative implications. The present study, aimed to evaluate the role of maternal serum uric acid and calcium versus Umbilical artery Doppler blood flow in preeclamptic patients at 28-30 weeks of gestation compared to Normotensive pregnant participants at El-Shatby Maternity University Hospital. There were significant negative correlations between serum calcium and UAPI across both preeclampsia groupings (mild and severe). Moreover, a significant positive correlations between serum uric acid and UAPI in both mild and severe preeclampsia groups. The preeclampsia group exhibited a significant decline in serum calcium levels, whereas serum uric acid levels and umbilical artery Doppler parameters showed a significant increase. These variations were more detectable in severe preeclampsia, suggesting their potential use as a predictive marker for preeclampsia severity.

Keywords

Copyright: © [2025] Asala et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License

(http://creativecommons.org/licenses/by/4.0/),

which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Future Perspectives of Medical, Pharmaceutical and Environmental Biotechnology
Volume 1, Issue 4
February 2025
Pages 1-10

Files

Share

How to cite

Statistics